Temporal distribution of dengue virus serotypes in Colombian endemic area and dengue incidence. Re-introduction of dengue-3 associated to mild febrile illness and primary infection

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue 7, 2006, Pages 725-731

  Ocazionez, Raquel Elvira ^a   Cortés, Fabián Mauricio ^a   Villar, Luis Angel ^a   Gómez, Sergio Yebrail ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

Dengue hemorrhagic fever; Dengue serotypes; Dengue 3; Polymerase chain reaction; Restriction site specific

Indexed keywords

DENGUE VIRUS;

EID: 33751295812     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762006000700004     Document Type: Article

References (40)

1. Álvarez A, Martínez H, Millán S, López L 2004. Diagnóstico de la Situación de Salud en Santander, 2nd ed., Secretaría de Salud de Santander, Santander, 56 pp.
2. Anderson C, Downs W, Hill A 1956. Isolation of dengue virus from a human being in Trinidad. Science 124: 224-225.
3. Boschell J, Groot H, Gacharna M, Márquez G, González M, Gaitán MO, Berlie CH, Martínez M 1986. Dengue en Colombia. Biomédica 6: 101-102.
4. Briceño-García B, Gómez-Dantés H, Argot-Ramirez E, Montesano R, Vázquez-Martínez AL, Ibañez-Bernal S, Madrigal-Ayal G, Ruiz-Matus C, Flisser A, Tapia-Coyner R 1996. Potential risk for dengue hemorrhagic fever: the Isolation of serotype Dengue-3 in Mexico. Emerg Infect Dis 2: 133-135.
5. Burke DS, Nisalak A, Johnson DE, Scott RM 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38: 172-180.
6. CDC-Centers for Disease Control 1995. Dengue type 3 infection-Nicaragua and Panama, October-November,1994. MMWR 44: 21-24.
7. De Simone TS, Nogueira RM, Araújo ES, Guimarães FR, Santos FB, Schatzmayr HG, Souza RV, Texeira Filho G, Miagostovich MP 2004. Dengue virus surveillance: the cocirculation of DENV-1, DENV-2 and DENV-3 in the state of Rio de Janeiro, Brazil. Trans R Soc Trop Med Hyg 98: 553-562.
8. Diaz JF 2004. Epidemiología molecular del dengue en las Americas. Memorias del primer simposio nacional de Virología, Universidad de Antioquia, Medellín, Colombia. Iatreia 17: 7 pp.
9. Endy TP, Nisalak A, Chunsuttitwat S, Vaugh DW, Green S, Ennis FA, Rothman AL, Libraty DH 2004. Relationship of preexisting dengue virus (DV) neutralizing antibodies levels to viremia and severity desease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189: 990-1000.
10. Fine P 1993. Herd immunity: history, theory, practice. Epidemiol Rev 15: 265-301.
11. Focks DA, Daniels E, Haile DG, Keesling JE 1995. A simulation model of the epidemiology of urban dengue fever. Literature analysis, model development, preliminary validation, and samples of simulation results. Am J Trop Med Hyg 53: 489-506.
12. Gomez SY, Méndez J, de Calvache D, Quintero J, Velandia M 2002. Circulación de virus dengue serotipo 3 en Colombia, 2002. II Congreso Nacional Investigación y Salud. Biomédica 22: 147 pp.
13. Gómez SY, Ocazionez RE, Cortés FM 2003. Caracterización genética de virus dengue que han circulado en el Departamento de Santander mediante amplificación simultánea de sitios para enzimas de restricción. Resúmenes del Congreso de la Asociación Colombiana de Parasitología y Medicina Tropical, 2003. Biomédica 23: 122 pp.
14. Gonçalvez A, Escalante A, Pujol FH, Ludert J, Tovar D, Salas R, Lipandri F 2002. Diversity an evolution of the envelope gene of dengue virus type 1. Virology 303: 110-119.
15. Gubler DJ 1997. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. In Gubler DJ, Kuno G (eds), Dengue and Dengue Hemorrhagic Fever, CAB International, Wallingford, p. 1-22.
16. Gubler DJ, Reed D, Rosen L, Hitchcock J 1978. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg 27: 581-589.
17. Halstead SB 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239: 476-481.
18. Harris E, Sandoval E, Xet-Mull AM, Johnson M, Riley LW 1999. Rapid subtyping of dengue viruses by restriction site-specific (RSS)-PCR. Virology 253: 86-95.
19. Harris E, Videa E, Perez L, Sandoval E, Tellez Y, Perez M, Cuadra K, Rocha J, Idiaquez W, Alonso R, Delgado M, Campo L, Acevedo F, Gonzalez A, Amador J, Balmaseda A 2000. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 2: 5-11.
20. Heinz FX, Collett MS, Purcell RH, Gould EA, Howard CR, Houghton M, Moormann R, Rice C, Thiel H 2000. Family Flaviviridae. In Virus Taxonomy. Seventh International Committee for the Taxonomy of Virases, Academic Press, San Diego, p. 859-878
21. Kliks S 1990. Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Res Hum Retroviruses 6: 993-998.
22. Kouri GP, Guzmán MG, Bravo JR, Triana C 1989. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull WHO 67: 375-380.
23. Lanciotti RS, Lewis JL, Gubler DJ, Trent DW 1994. Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 75: 65-75.
24. Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM 2003. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 9: 800-809.
25. Miagostovich MP, dos Santos FB, Fumian TM, Guimarães FR, da Costa EV, Tavares FN, Tavares FN, Coelho JO, No-gueira RM 2006. Complete genetic characterization of a Brazilian dengue virus type 3 strain isolated from a fatal outcome. Mem Inst Oswaldo Cruz 101: 307-313.
26. Ministerio de Salud y Protección Social. Instituto Nacional de Salud. Vigilancia virológica del dengue en Colombia 2002. URL./ http://www.ins.gov.co/pdf_investiga/v_dengue
27. Nogueira RM, Miagostovich MP, Filippis AMB, Pereira MAS, Schatzmayr HG 2001. Dengue virus type 3 in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 96: 925-926.
28. Nogueira RM, Schatzmayr HG, Filippis AMB, Santos FV, Cunha RV, Coehlo JO, Souza LJ, Guimarães FR, Araújo ESM, De Simone TS, Baran M, Texeira G, Miagostovich MP 2005. Dengue virus type 3, Brazil, 2002. Emerg Infect Dis 11: 1376-1381.
29. Ocazionez R, Cortés F, Villar LA 2005. Vigilancia del dengue basada en el laboratorio: diferencias en el número de casos y virus aislados según la recolección del suero y la prueba serológica. Colombia Médica 36: 65-72.
30. Ospina MC 2004. Vigilancia epidemiológica del dengue en Antioquia. Memorias del 1er. Simposio Nacional de Virología, Medellín 2004. Iatreia 17: 9 pp.
31. PAHO 2000-2004. Number of reported cases of dengue & dengue hemorrhagic fever (DHF). Region of the Americas (by country and subregion). URL./ http://www.paho.org/english/ad/dpc/cd/dengue
32. Pancharoen C, Kulwichit W, Tantawichien T, Thysiakorn U, Thisyakorn C 2002. Dengue infection: a global concern. J Med Assoc Thai I: S25-33.
33. Passos M, Santos L, Pereira M, Casali CG, Fortes B, Ortiz Valencia L, Alexandre J, Medronho R 2004. Clinical differences observed in patients with dengue caused by different serotypes in the epidemic of 2001/2002, occurred in Rio de Janeiro. Rev Soc Bras Med Trop 37: 293-295.
34. Peláez O, Guzmán MG, Kouri G, Pérez R, San Martín JL, Vásquez S, Rosario D, Mora R, Quintana I, Bisset J, Cancio R, Mesa AM, Castro O, González D, AvilaL C, Rodriguez R, Alvarez M, Pelegrino JL, Bernardo L, Prado I 2004. Dengue 3 Epidemic, Havana, 2001. Emerg Infect Dis 10: 719-722.
35. Pinheiro F, Corber S 1997. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat Q 50: 161-169.
36. Rico-Hesse R, Harrison L, Salas R, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa M, Nogueira R, Travassos da Rosa A 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230: 244-251.
37. Rigau J, Ayala A, García E, Hudson S, Vordam V, Reiter P, Cano M, Clark G 2002. The reappearance of dengue-3 and a subsequent dengue-4 and dengue-1 epidemic in Puerto Rico. Am J Trop Med Hyg 67: 355-362.
38. Uzcategui N, Comach G, Camacho D, Salcedo M, Cabello de Quintana M, Jimenez M, Sierra G, Cuello de Uzcategui R, James WS, Turner S, Holmes E, Gould E 2003. Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virology 84: 1569-1575.
39. Vorndam V, Beltran M 2002. Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses. Am J Trop Med Hyg 66: 208-212.
40. WHO 1980. Guide for diagnosis, treatment and control of dengue hemorrhagic fever. Technical Advisory Committee on Dengue hemorrhagic fever for the South East Asian and Western Pacific regions, Geneva.